| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |